Deendar Channabasaveshwara terror case: Beggar arrested after 16 years

Mangaluru, Jan 18: The Muslim Central Committee of Dakshina Kannada and Udupi has claimed that around 3 lakh people had gathered at Shah Gardan, Adyar-Kannur in Mangaluru on January 15, even though their expectation was just 1 lakh people.

The protest against CAA, NPR, NRC and police atrocities against minorities was jointly being organised by the various Muslim organisations of twin district under the leadership of Muslim Central Committee.

“We had just expected around 1 lakh people. But the Mangaluru witnessed the largest gathering in its history on Jan 15. Around 3 lakh people had participated in the protest,” Ibrahim Kodichail, vice president of the committee told media persons today.

K S Mohammed Masood, president of the committee, added that the event was a grand success and fretful, besides being peaceful. He wholeheartedly thanked all those who strived hard to make the protest a great success and to those who had taken part in it.

“At least 28 organisations have come together. As a result 3 lakh people assembled. I thank all those organisations,” he said.

He also opined that police too had helped to maintain law and order and cooperated with the protesters at the venue.

SM Rasheed Haji, B M Mumtaz Ali, Syed Ahmed Basha Thangal, Kasim Ahmed H K and Mansoor Ahmed Azad were present at the press meet among others.

Mangaluru, May 2:  Dakshina Kannada district administration has taken steps to quarantine people returning after having lost their jobs in foreign countries.

Marriages hall, general halls and hostels are being identified for the purpose, a source said.

Official said that Coronavirus scare also has forced many people from foreign countries, those in including Gulf countries, to return to their native villages.

The Gulf countries are also sending back those staying illegally there. 

Once the flight services resume, thousands of people are likely to return to the country.

Meanwhile, DK deputy commissioner Karnataka held a video conference with Chief Minister BS Yediyurappa.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.